Astrazeneca PLC (AZN)



AstraZeneca is a prescription-based biopharmaceutical company. Co. discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology and Respiratory and Inflammation. Co. maintains a range of products which includes a number of key products such as: Arimidex (for breast cancer), Crestor (for managing cholesterol levels), Nexium (for acid reflux), Seroquel (for schizophrenia and bipolar disorder), Synagis (for RSV, a respiratory infection in infants) and Symbicort (for asthma and chronic obstructive pulmonary disease). Co. is active in over 100 countries.

Data as of 2020-07-04
Market Cap141.2 Billion Shares Outstanding2.625 Billion Avg 30-day Volume6.144 Million
P/E Ratio92.0 Dividend Yield3.532 EPS0.95
Price/Sales0.097 Price cash flow ratio39.7 Price free cash flow ratio-53.5
Book Value4.11 Price to Tangible Book-6.77 Alpha0.01
Short Interest Ratio0.47 % Short Interest to Float0.1 R-squared0.236596
BETA0.868836 52-week High/Low57.44 / 36.15 Stddev0.076066
View SEC Filings from AZN instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 13 4 (0.26%)
13F Filers holding this stock: 576 108 (7.07%)
Aggregate 13F shares on 03/31/2020: 441.606 Million 210.022 Million
Aggregate 13F shares on 12/31/2019: 446.826 Million 211.619 Million
Percent change: -1.17% -0.75%
Funds creating new positions: 63 13
Funds Adding to an existing position: 188 40
Funds closing out their position: 83 28
Funds reducing their position: 217 39
Heat Map Ranking for 03/31/2020 338
Heat Map Ranking for 12/31/2019 306
1 hedge funds as identified by through public filings.

Funds Holding AZN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AZN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)


Open Market Sells (S)


Exercise Derivative Conversion (M)


Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments